Science Explorer Back to mapMap
Discussion
Researcher · Clinique Saint Jean Languedoc · France

Franck Bürki

Franck Bürki publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Rheumatology, on topics such as Colorectal Cancer Treatments and Studies, Breast Cancer Treatment Studies and Cancer Treatment and Pharmacology.

OpenAlex
World rank
#4,651,463
of 7,710,434 ranked researchers
Rank in France
#195,924
of 324,115
Works
29
Citations
763
Citations per work
26.3
h-index
7
i10-index 7Top 78% in Oncology
Franck Bürki

What does Franck Bürki research?

Franck Bürki's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 19 works · 66.7% of their workMedicine: 19 works · 66.7% of their workOncology: 8 works · 28.2% of their workPulmonary and Respiratory Medicine: 4 works · 15.4% of their workRheumatology: 3 works · 9.0% of their workPathology and Forensic Medicine: 2 works · 7.7% of their workSurgery: 2 works · 6.4% of their workEverything else: 7 works · 25.6% of their workLife Sciences: 2 works · 7.7% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 7.7% of their workCancer Research: 2 works · 7.7% of their workTHEIR WORKFranck Bürki29works
Life Sciences8%Health Sciences67%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1966.7%
  2. Everything else725.6%
    1. Biochemistry, Genetics and Molecular Biology27.7%
  1. 1Oncology28% of their works
  2. 2Pulmonary and Respiratory Medicine15% of their works
  3. 3Rheumatology9% of their works
  4. 4Cancer Research8% of their works
  5. 5Pathology and Forensic Medicine8% of their works
  6. 6Surgery6% of their works

Research topics

Which keywords describe Franck Bürki's research?

The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Molecular Subtypes, Breast Cancer, Metastatic Breast Cancer, Survival Analysis, Cetuximab and KRAS Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Chemotherapy154 topics
  2. Clinical Practice Guidelines113 topics
  3. Molecular Subtypes112 topics
  4. Breast Cancer103 topics
  5. Metastatic Breast Cancer82 topics
  6. Survival Analysis82 topics
  7. Cetuximab61 topic
  8. KRAS Mutations61 topic
  9. Breast Tumours51 topic
  10. Chemotherapy-Induced Peripheral Neuropathy51 topic
  11. Gene Expression51 topic
  12. Taxanes51 topic
  13. HER241 topic
  14. Trastuzumab41 topic
  15. Bisphosphonates31 topic
  16. CDK4/6 Inhibitors31 topic
  17. Endoscopic Resection31 topic
  18. Gastric Cancer31 topic
  19. Osteonecrosis of the Jaw31 topic
  20. Palbociclib31 topic
  21. DNA21 topic
  22. Topoisomerases21 topic

Where does Franck Bürki work?

Franck Bürki's main affiliation in the publication record is Clinique Saint Jean Languedoc, France.

How many publications and citations does Franck Bürki have?

OpenAlex counts 29 works and 763 citations for Franck Bürki, an h-index of 7, ranking #4,651,463 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Franck Bürki. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.